| 1 | Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults. 2022;21: doi: 10.1186/s12944-021-01617-3 |
| 2 | Expanding donor pool for live donor liver transplantation: utilization of donors with non-alcoholic steatohepatitis after optimization. 2022;407:1575 doi: 10.1007/s00423-022-02444-5 |
| 3 | Comparison of the role of alcohol consumption and qualitative abdominal fat on NAFLD and MAFLD in males and females. 2022;12: doi: 10.1038/s41598-022-20124-8 |
| 4 | Non-alcoholic Steatohepatitis: Global Impact and Clinical Consequences. 2022;74 doi: 10.33590/emjhepatol/22-00150 |
| 5 | Validation of five hepatic steatosis algorithms in metabolic‐associated fatty liver disease: A population based study. 2022;37:938 doi: 10.1111/jgh.15799 |
| 6 | Accuracy of Ultrasonography vs. Elastography in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review. 2022; doi: 10.7759/cureus.29967 |
| 7 | Metabolically healthy obese and MAFLD: does weight status alone matter?. 2022;16:1253 doi: 10.1007/s12072-022-10433-5 |
| 8 | Precision medicine in nonalcoholic fatty liver disease. 2022;37:1175 doi: 10.1111/jgh.15850 |
Metabolism and Target Organ Damage
